US Stock MarketDetailed Quotes

Vor Biopharma (VOR)

Watchlist
  • 14.060
  • -0.710-4.81%
Close Jan 15 16:00 ET
  • 14.370
  • +0.310+2.20%
Pre 07:24 ET
544.41MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vor Biopharma (VOR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.42%28.11M
844.67%274.28M
2.99%33.29M
-3.85%121.19M
11.33%31.31M
-19.26%28.51M
-9.76%29.04M
6.26%32.33M
34.92%126.04M
13.75%28.12M
Selling and administrative expenses
108.56%13.97M
77.27%12.79M
-17.67%6.59M
-12.12%27.88M
-17.49%5.96M
-13.15%6.7M
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
-General and administrative expense
108.56%13.97M
77.27%12.79M
-17.67%6.59M
-12.12%27.88M
-17.49%5.96M
-13.15%6.7M
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
Research and development costs
-35.18%14.14M
1,098.27%261.5M
9.78%26.7M
-1.07%93.31M
21.30%25.35M
-20.97%21.82M
-8.68%21.82M
10.98%24.32M
46.11%94.32M
22.48%20.9M
Operating profit
1.42%-28.11M
-844.67%-274.28M
-2.99%-33.29M
3.85%-121.19M
-11.33%-31.31M
19.26%-28.51M
9.76%-29.04M
-6.26%-32.33M
-34.92%-126.04M
-13.75%-28.12M
Net non-operating interest income expense
81.45%1.73M
-55.10%537K
-47.11%805K
-47.74%4.27M
-67.85%599K
-55.13%954K
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
Non-operating interest income
81.45%1.73M
-55.10%537K
-47.11%805K
-47.74%4.27M
-67.85%599K
-55.13%954K
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
Other net income (expense)
-786.31M
-1.3B
Gain on sale of security
---790.46M
---1.3B
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
--4.15M
----
----
----
----
----
----
----
----
----
Income before tax
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Income tax
Net income
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Net income continuous Operations
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Minority interest income
Net income attributable to the parent company
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
Basic earnings per share
-1,410.93%-121.63
-2,963.41%-251.2
42.22%-5.2
2.86%-34
-15.13%-8.75
17.86%-8.05
8.89%-8.2
-4.65%-9
24.89%-35
26.92%-7.6
Diluted earnings per share
-1,410.93%-121.63
-2,963.41%-251.2
42.22%-5.2
2.86%-34
-15.13%-8.75
17.86%-8.05
8.89%-8.2
-4.65%-9
24.89%-35
26.92%-7.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.42%28.11M844.67%274.28M2.99%33.29M-3.85%121.19M11.33%31.31M-19.26%28.51M-9.76%29.04M6.26%32.33M34.92%126.04M13.75%28.12M
Selling and administrative expenses 108.56%13.97M77.27%12.79M-17.67%6.59M-12.12%27.88M-17.49%5.96M-13.15%6.7M-12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M
-General and administrative expense 108.56%13.97M77.27%12.79M-17.67%6.59M-12.12%27.88M-17.49%5.96M-13.15%6.7M-12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M
Research and development costs -35.18%14.14M1,098.27%261.5M9.78%26.7M-1.07%93.31M21.30%25.35M-20.97%21.82M-8.68%21.82M10.98%24.32M46.11%94.32M22.48%20.9M
Operating profit 1.42%-28.11M-844.67%-274.28M-2.99%-33.29M3.85%-121.19M-11.33%-31.31M19.26%-28.51M9.76%-29.04M-6.26%-32.33M-34.92%-126.04M-13.75%-28.12M
Net non-operating interest income expense 81.45%1.73M-55.10%537K-47.11%805K-47.74%4.27M-67.85%599K-55.13%954K-45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M
Non-operating interest income 81.45%1.73M-55.10%537K-47.11%805K-47.74%4.27M-67.85%599K-55.13%954K-45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M
Other net income (expense) -786.31M-1.3B
Gain on sale of security ---790.46M---1.3B--------------------------------
Other non- operating income (expenses) --4.15M------------------------------------
Income before tax -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Income tax
Net income -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Net income continuous Operations -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Minority interest income
Net income attributable to the parent company -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M
Basic earnings per share -1,410.93%-121.63-2,963.41%-251.242.22%-5.22.86%-34-15.13%-8.7517.86%-8.058.89%-8.2-4.65%-924.89%-3526.92%-7.6
Diluted earnings per share -1,410.93%-121.63-2,963.41%-251.242.22%-5.22.86%-34-15.13%-8.7517.86%-8.058.89%-8.2-4.65%-924.89%-3526.92%-7.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -